Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Ohio: Big Drug Companies Have Spent Over $62 Million to Defeat Issue 2

Ohio Taxpayers for Lower Drug Prices
Posted on: 02 Nov 17

Big drug companies have spent over $62 million to lie and distort the truth about Yes on Issue 2, marking what is sure to be the most expensive statewide ballot issue campaign ever in Ohio.

Link to the ‘Yes on Issue 2’ campaign’s “Ohio Isn’t for Sale’ TV spot:
A new ad from Yes on Issue 2 points out this outrageous corruption of power:

“These big drug companies can’t stand the thought of having to actually take a hard look at their drug pricing, so they’re spending literally as much as they possibly can – from very deep pockets I might add – to confuse voters and get them to stay home or vote No. They’re buying this election,” said Dennis Willard, spokesperson for Yes on Issue 2.“These are the same big drug companies who raised the price of EpiPens by hundreds of dollars, make Hepatitis medication prohibitively expensive, and used their considerable power and money to lobby Congress and create the opiate epidemic. They are not on the side of regular, working Ohioans.”

Background on Ohio Ballot Issue 2

The Yes on Issue 2 campaign is a broad-based, bi-partisan coalition. More than 200,000 Ohio voters signed petitions to put an amendment on the ballot in November that will lower drug prices for over 4 million Ohioans, including 164,000 children, save taxpayers $400 million annually, reduce healthcare costs for everyone and teach greedy drug companies and their CEOs a lesson.

You can learn more by visiting or following us on Facebook and Twitter.

Paid for by Ohio Taxpayers for Lower Drug Prices

View source version on

Business Wire

Last updated on: 02/11/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.